Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Sun Pharma gains 3%; hits new high on UBS 'Buy' rating, sees more upside

UBS has a target price of Rs 2,450 on Sun Pharma and expects it to record the highest growth in the near-term and the medium-term via a ramp-up of the specialty drug pipelline.

By: business-standard.com

Sep 27 2024
0
0 Views

Sun Pharma gains 3%; hits new high on UBS 'Buy' rating, sees more upside

Related

HDFC AMC jumps 17% in seven days; crosses 1-trillion MCap

Dabur India fixes record date for interim dividend

INR rises 4 paise to settle at 84 against US dollar

Sai Industries reports standalone net loss of Rs 0.01 crore in the September 2024 quarter

Tips Music standalone net profit rises 21.46% in the September 2024 quarter

TVS Credit Services consolidated net profit rises 19.40% in the September 2024 quarter

Himadri Speciality Chemical consolidated net profit rises 34.50% in the September 2024 quarter

JM Financial Services Pvt standalone net profit rises 163.02% in the September 2024 quarter

Kritika Wires standalone net profit rises 20.20% in the September 2024 quarter

Nifty October futures trade at premium

Auto shares slide

Consumer goods stocks edge lower

HDFC AMC jumps 17% in seven days; crosses 1-trillion MCap